Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article